Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Thrombospondin 1 ELISA Kit (AC2733)
Cat.#: ASET-1322
Specifications
Description Rat Thrombospondin 1 ELISA Kit allows for the in vitro quantitative determination of rat Thrombospondin 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 1.875 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 3.125-200 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1966 Human DAG1 ELISA Kit (AC3377) Quantitative inquiry ASET-1084 Mouse C1qtnf5 ELISA Kit (AC2495) Quantitative inquiry ASET-2082 Human LAMB3 ELISA Kit (AC3493) Quantitative inquiry ASET-1235 Human Cadherin 10 ELISA Kit (AC2646) Quantitative inquiry ASET-1679 Human Synaptogyrin 3 ELISA Kit (AC3090) Quantitative inquiry ASET-1142 Human SHANK3 ELISA Kit (AC2553) Quantitative inquiry ASET-1567 Human VCP ELISA Kit (AC2978) Quantitative inquiry ASET-2089 Chicken CNTF ELISA Kit (AC3500) Quantitative inquiry ASET-2374 Mouse NT-4 ELISA Kit (AC3785) Quantitative inquiry ASET-1453 Human Neurofibromin ELISA Kit (AC2864) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket